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Abstract
Background: The American Psychosomatic Society is one of the oldest and probably the most influential
scientific society in psychosomatic/biopsychosocial research worldwide. The current article delineates the
historical development and current strategic orientation of the society.
Method: Review of published literature, archived materials and current documents of the society.
Results: The American Psychosomatic Society (APS) was founded in 1942, originally named the “American
Society for Research in Psychosomatic Problems “. It originated from the editorial board of the Journal Psychosomatic
Medicine, which had already been founded in 1939 and has become one of the major journals in the field. As an
organization, APS has developed into a premier international scientific society, providing an interdisciplinary home for
researchers from medicine, psychology and related areas, gathering under the mission “to advance and integrate the
scientific study of biological, psychological, behavioral and social factors in health and disease” and dedicated to the
goals of Scientific Excellence, Clinical Relevance, and Vibrant and Diverse Membership. Besides editing Psychosomatic
Medicine, the APS organizes Annual Meetings and specialized events, issues several scientific awards and scholarships
and is engaged in collaborative efforts to improve the research and funding landscape for biobehavioral research in
the US and translate psychosomatic research findings into medical education and clinical practice.
Conclusion: In its 75th anniversary year, the American Psychosomatic Society has developed into the scientific
landscape of the 21st century, and its current updated strategy addresses contemporary demands in advancing science
and improving holistic patient care.
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The beginnings
The origin of Psychosomatic Medicine in the United States
of America is often attributed to Helen Flanders Dunbar of
New York and her publication in 1935 of “Emotions and
Bodily Changes, A Survey of Literature on Psychosomatic
Interrelationships 1910-1933” [1]. On almost 600 pages,
Dunbar addressed theoretical and methodological founda-
tions of psychosomatic research before reviewing the litera-
ture on psychosomatic aspects of organs, organ systems,
and their disorders and concluding with some therapeutic
considerations. More than 100 pages are devoted to an ex-
haustive bibliography covering an enormous 2251 refer-
ences available at that time.
In the Introduction, Dunbar starts by stating that
“Scientific study of emotion and of the bodily changes
that accompany diverse emotional experience marks a
new era in medicine. We know now that many physio-
logical processes which are of profound significance for
health, not only of the individual but also of the group,
can be controlled by way of the emotions. In this know-
ledge we have the key to many problems in the preven-
tion and treatment of illness, yet we have scarcely
begun to use what we know… Furthermore, we have
reached a point where progress in the specialties
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themselves is being blocked by a lack of understanding
of the relationships between them” ([1], p. xi).
When turning to organ systems, It appeared logical for
the author to put the nervous system first, arguing that “It
is customary to assume that the seat of the psyche is in
the brain; … In glancing through the succeeding chapters,
however, the reader will find it to have been said with
equal emphasis that the seat of the psyche is in the heart,
or in the ϕρήν, or in the ‘guts,’ etc.… In other words, study
of any organ-system reveals the psyche there, and we find
ourselves forced to give up the idea of a ‘localization’ of
the psyche in any particular part of the body” ([1], p. 117).
Few years later, in 1939, Dunbar was the driving force
behind the foundation of the Journal “Psychosomatic
Medicine”. She became the first managing editor and a
member of the editorial board representing psychiatry,
together with the Chicago-based psychoanalyst Franz
Alexander, Howard Liddell, representing comparative
physiology, the internist Dana Atchley of New York and
the pediatrician Grover Powers from Yale. Stanley Cobb
represented neurology, Hallowell Davis physiology, and
Clark Hall psychology. Theodore P. Wolfe was appointed
as review editor without specialty assignment [2]. In the
introductory statement the authors of the new Journal
outlined the area of Psychosomatic Medicine as follows:
“Psychosomatic Medicine is not equivalent with what
is understood by the term psychiatry. Psychiatry is
concerned with the study and therapy of the
disturbances of the mind whether these disturbances
are the results of emotional experiences, or of
anatomical changes (degenerative, inflammatory
processes, or neoplasms) of the central nervous
system. The principal interest of psychiatry is the
diseased mind. Psychosomatic Medicine covers a
different and broader field. Its object is to study in
their interrelation the psychological and physiological
aspects of all normal and abnormal bodily functions and
thus to integrate somatic therapy and psychotherapy.
Psychosomatic Medicine is not restricted to any
specific field of pathology. Medical specialties such as
internal medicine, pediatrics, dermatology,
ophthalmology, etc., may be so restricted.
Psychosomatic Medicine, however, is not a medical
specialty of this kind; it designates a method of
approach to the problems of etiology and therapy
rather than a delimitation of the area" ([3]; p. 3).
In its first years, the journal Psychosomatic Medicine was
jointly controlled by the Editorial Board and the funders of
the Journal, namely the Josiah Macy, Jr., Foundation and
the US National Research Council. The first issue of the
Journal went out to almost 100 subscribers, just 8 months
before the beginning of World War II. Under increased
economic pressure produced by the U.S. involvement in
the war, both personal and material resources for the pro-
duction of the journal became more and more limited and
dissatisfaction with the sharing of responsibilities between
the Editorial Board and the journal funders increased, lead-
ing Dunbar to proposing the foundation of an “American
Society for Research in Psychosomatic Problems” as an
organization to lend institutional stability to the journal [2].
There was some controversial discussion about found-
ing a new society and some people “suggested that this
should be postponed in view of the present emergency”.
However, a large majority stated that “because of the
present emergency and the demand for further research
in psychosomatic problems no time should be lost.” [4].
In a 1959 article in JAMA, the medical historian Gregory
Zilboorg [5] retrospectively argued that “from the stand-
point of historical perspective, the development of psycho-
somatic medicine was not necessarily a result of World
War II” but that “born out of historical necessity, psycho-
somatic medicine remains overburdened with new prob-
lems which medicine seems to be unable to solve and
which psychiatry is as yet able merely to give names.”
The new society held its inaugural meeting in New York
City on December 18, 1942, with a main thematic focus
on fatigue [4]. Instead of an expected 50 participants (due
to war-related government restrictions on travel and the
short notice given of the meeting), almost 300 persons
attended the one-day meeting. At the following meeting
in May, 1943, Tracy Putnam, a Boston Neurologist, be-
came the first President of the society and several other
officers and Council members were elected. Since then,
presidents changed annually, but although the initiator of
the society had been a woman, she never became presi-
dent and it lasted until 1972 that Margaret Singer became
the first female – and also the first Ph.D. – President [6].
In the first years, both the Journal and the Society –
despite their explicitly interdisciplinary self-concept - were
mainly influenced by psychoanalytically trained psychia-
trists. After the end of the war, the interest in psychosomatic
medicine increased substantially, as did subscriptions to the
Journal, which had approximately 2000 subscribers in 1946,
while the society had grown to 452 members who were or-
ganized in several specialized committees [2].
In November of 1947, the Council decided to change
the name of the Society to the “American Psychosomatic
Society” [7]. It gave up the intention to “attempt to
organize and direct or subsidize research in psycho-
somatic medicine or in any of the allied disciplines. It
was felt that in the present phase of the development of
psychosomatic medicine the Society's function could be
best expressed by offering itself as a forum in which the
various groups working in psychosomatic medicine
could present the results of their investigations and in
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which they would be informed of work being done in
their respective fields.” [8].
Decades of development
By 1951 the membership had risen to >500 [9].
However, in the late 1950s the APS and North American
psychosomatic medicine were perceived as being in a crisis.
Zilboorg [5], although calling psychosomatic medicine the
“most conspicuous and dramatic postwar development”
stated that “whether psychosomatic medicine is here to
stay as a specialty, or a subspecialty, is doubtful.” and “The
future of this synthesis (of psychoanalysis, psychiatry, and
medicine, CH-L) is as yet neither clear nor otherwise
determined.”
In his Presidential Address, Wittkower [10] reported
on an analysis of studies published in Psychosomatic
Medicine over 20 years and found that the percentage of
articles with sole or senior authors who were psychia-
trists had increased from 60% in the first years to 74% in
1954–58 and that the percentage of neurologists or
other medical specialists had in the same time dropped
from 22% to only 7%, while the contributions of epide-
miologists and of social scientists had remained “regret-
tably small”. Wittkower also observed a shift from more
clinical to more experimental and conceptual research
and stated that “there is a growing cleavage noticeable in
psychosomatic publications between those with more
and more psychiatry and less and less physiology, and
those with more and more physiology and less and less
psychiatry.” [10] In his conclusion, Wittkower assumed
that as a result of “fragmentation into particularistic in-
terests” and a “decline in interest in psychosomatic
medicine on the part of physicians” psychosomatic
medicine had “entered a crisis that threatens its very ex-
istence. It has been stated often that psychosomatic
medicine is not a specialty, but an approach with a com-
mon focus on which workers in different fields converge,
and that it works toward its own dissolution— assuming
general acceptance of a multifaceted perspective of
health and illness, with acknowledgment of the relevance
of emotional factors to, and the pluricausality of, illness.
The question may be raised whether this phase in the
development of our field has been reached, and whether,
consequently, psychosomatic medicine as such has lost
its usefulness as a collaborative endeavor.” ([10]; p.313)
Wittkower tended to answer this question to the nega-
tive and referred to – at that time – recent integrative
concepts of the field by Grinker, Bandler, Engel and
others, calling for a comprehensive, multidisciplinary ap-
proach to the field.
Interestingly it was in the same year of perceived crisis
in North American psychosomatic medicine that the
Japanese Psychosomatic Society held its inaugural meet-
ing in Tokyo and started its impressive development. In
preparation for that meeting, the APS was requested to
answer a number of questions about the nature of psy-
chosomatic medicine and psychosomatic disease. In an
Editorial, Binger [11] answered as follows: “Psycho-
somatic medicine is another name for comprehensive or
holistic medicine. In other words, it is a point of view
toward the study of illness and disease and an approach
toward research. It includes the individual's reactions to
his illness and its implications for his personal and social
life as well as the effects of these upon the functioning
of his body. … there is no such thing as psychosomatic
disease. All disease can be looked at from this point of
view. … The goal of psychosomatic research is to ex-
plore and clarify the interrelationship of psychological
processes and physiological and pathological ones, with
the hope of achieving a clearer understanding of what
illness consists of. … The proper future of psycho-
somatic medicine is its disappearance, with replacement
by a true holistic or comprehensive medicine.”
However, little progress seems to have been made to-
wards this goal in the subsequent ten years. In his Presi-
dential Address ten years later Mason [12] regretted that
“realistically, we must face the fact that the psycho-
somatic approach has not as yet had the sweeping, revo-
lutionary impact on medicine of which it appears
capable.” He proposed strategies for improved multidis-
ciplinary research on the mechanisms involved in psycho-
somatic illnesses to cover the complexity of processes
involved. Such multidisciplinary research might require
collaborations on a national rather than local level. He
concluded that “The future almost certainly will require
some revolutionary departures from conventional prac-
tices in order for the integrative approach to become
firmly established in medicine. If this is to be done in the
near future, almost certainly we here in this room and our
successors must do it.” ([12]; p. 439) .
Interestingly, Presidential Addresses from subsequent
years (eg, [13–16]) were more likely to report on specific
research methods, original study data and advancements
in psychosomatic medicine rather than discussing the
future of psychosomatic medicine or research per se.
However, in 1979 Graham [17] discussed “Psycho-
somatic medicine’s place in medicine”. He agreed with
the former APS President George L. Engel’s seminal
Science paper [18], where Engel stated that “Psycho-
somatic medicine-the term itself a vestige of dualism-
became the medium whereby the gap between the two
parallel but independent ideologies of medicine, the bio-
logical and the psychosocial, was to be bridged. Its pro-
gress has been slow and halting, not only because of the
extreme complexities intrinsic to the field itself, but also
because of unremitting pressures, from within as well as
from without, to conform to scientific methodologies ba-
sically mechanistic and reductionistic in conception and
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inappropriate for many of the problems under study.
Nonetheless, by now a sizable body of knowledge, based
on clinical and experimental studies of man and animals
has accumulated. Most, however, remains unknown to
the general medical public and to the biomedical com-
munity and is largely ignored in the education of physi-
cians. … The fact is that medical schools have
constituted unreceptive if not hostile environments for
those interested in psychosomatic research and teaching,
and medical journals have all too often followed a
double standard in accepting papers dealing with
psychosomatic relationships” ([18]; p. 134). Graham there-
fore recommended the Society to “return a little towards
its former emphasis on the understanding of 'medical' dis-
ease. This suggestion is no way intended to disparage
basic research.” [17] Based on that better understanding
Graham called for “more evidence that psychological ap-
proaches are of therapeutic value in patients with medical
diseases” with “particular emphasis on improvements in
the technique of therapeutic interviewing” [17].
As time progressed, Jenkins [19] found psychosomatic
medicine in a process of differentiation – with an in-
creasing number of subspecialty journals addressing the
field which had previously only be covered by the APS
journal Psychosomatic Medicine and that “many more
general scientific and medical journals regularly accept
papers which are basically psychosomatic than was the
case in earlier years.” The APS membership had grown
to 950 by 1984. However, Jenkins stated that psycho-
somatic research still paid insufficient attention to indi-
viduals’ environments, cultural factors and to persons in
childhood, old age or minority populations, as well as to
treatments and rehabilitation for major illnesses, which
he considered desirable for the future.
A membership survey conducted in 1987 [20] found
that still >75% of APS members were MDs and the ma-
jority of them were psychiatrists. Only 13% of members
were internists or pediatricians, while psychologists and
sociologists made up 22.5%. However, the numbers only
partially reflect the profound changes in membership
that had occurred since the 1960s and continued to
occur in later years: The initially strong influence of sci-
entifically active internists slowly mellowed out as many
internists retired or shifted their focus from research to
teaching psychosomatic understanding and communica-
tion skills. Consultation programs in psychiatry were de-
veloped and many consultation psychiatrists turned
away from the APS to join the Academy for Psycho-
somatic Medicine (APM), founded in 1954. The APM as
a more clinically oriented society provides consultation-
liaison psychiatrists with research findings directly help-
ing them with clinical decision making, while the APS
increasingly focused on research in psychobiological
mechanisms. This split partly reflected changes in
funding for medical schools in the U.S., which left little
time for physicians to engage in research. Physicians
who wanted to do research needed to obtain grant fund-
ing. Yet this was difficult to obtain without sufficient
training in research methodologies, which is not rou-
tinely provided during medical education. In psychology
new areas of research, namely health psychology and be-
havioral medicine with their organizations, competed
with APS for clinically oriented members and impact.
Taken together these changes led to a gradual reduction
in clinical integration and intervention research.
APS’ 50th anniversary was celebrated with a large
international meeting held in New York in 1992. At that
time, the Society had, in 1986, appointed a professional
manager and was financially healthy due to a new pub-
lisher and contract for the Journal Psychosomatic Medi-
cine which generated substantially increased and reliable
royalties. These changes gave the Society the opportun-
ity to engage more in committee work and press rela-
tions. Awards and scholarship programs were created
and the Society started a newsletter as one of several
measures to keep members more actively involved [2].
The anniversary meeting was co-sponsored by 16 US
and international societies of related disciplines. Some
40% of attendees came from outside North America and
approximately 50% were MDs. According to the confer-
ence organizers, the program reflected “the transition
from the study of a disease which had been labeled ‘psy-
chosomatic’ to studies of psychobiologic processes.” [2]
However, a major focus of the meeting was also on
consultation-liaison psychiatry and a two-day preconfer-
ence was dedicated to hypnosis.
However, despite several efforts to keep the balance
between psychosomatically-oriented internists or other
medical specialists on one hand and consultation-liaison
psychiatrists on the other, and between clinicians and
more basic researchers, the clinical focus in APS dimin-
ished further in the following two-and-a-half decades.
The position of Ph.D.s in the Society was strengthened
in order to meet the interests of health psychologists
and basic researchers. This undoubtedly led to a strong
research record of the APS membership whose publica-
tions now appear in highly ranked medical and psycho-
logical journals, in addition to the continuously high
quality of research published in Psychosomatic Medicine.
One important initiative in this context focused on
advancing neuroscience in psychosomatic research by
organizing dedicated symposia at APS meetings, review-
ing relevant literature in several articles in Psycho-
somatic Medicine and encouraging original research by,
eg, the donation of a dedicated annual award [21].
M.D. members lost their majority in the Society in
2001 and never again reached a portion of >50% of APS
members. Since 2009 M.D.s make up some relatively
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stable 30% of the membership. The decline in the num-
bers of (often older) M.D. members went along with an
increase in younger members (<47 y/o) from 25% in
2000 to a maximum of 46% in 2014 and a related in-
crease in members holding neither an M.D. nor Ph.D.
degree from 10% in 2000 to approximately 20% in recent
years (unpublished data). Over the last 20 years, APS
Presidents have been alternating at approximately equal
rates between M.D.s and Ph.D.s [6].Young members and
international researchers have been attracted successfully
by a variety of travel scholarships and similar programs
while all efforts of increasing the number of M.D. mem-
bers again showed little effect.
In contrast to this development in APS, institution-
alized psychosomatic medicine gained increased credit
by the creation of a subspecialty in “Psychosomatic
Medicine” for psychiatrists in 2005, mainly reflecting
consultation-liaison psychiatry. However, the new spe-
cialty found little resonance in the APS and most
clinical psychiatrists specialized in “Psychosomatic
Medicine” are now organized in the Academy of Psy-
chosomatic Medicine, while the majority of APS
members is nowadays made up by non-physician
researches.
The quest for APS’ identity in the 21st century
The decreasing number of M.D. members and the paral-
lel increase in basic “mechanistic” research (a term that
still had negative connotations in earlier years of the so-
ciety; see [18]) almost inevitably led to long-lasting dis-
cussions about a possible change of the society’s and its
journal’s names.
As early as in 1960, Wittkower [10] had stated in his
Presidential Address mentioned above that “The future
of psychosomatic medicine, to repeat, lies in a multidis-
ciplinary approach. However, it may be seriously ques-
tioned whether the outcome of such a comprehensive
multidisciplinary study would still be justifiably and
adequately covered by the term 'psychosomatic'.” [10].
In 1977, an ad-hoc committee was created to consider
a name change or a subtitle for the journal “Psycho-
somatic Medicine”. After several months of discussion
the committee decided to keep the name of the journal
and also not to add anything to it. However, with its 70th
anniversary in 2009, the editors of Psychosomatic Medi-
cine – with the approval by the APS Council – finally
added the subtitle “Journal of Biobehavioral Medicine”
to the (unchanged) name of the journal. When the sub-
title was added to the journal, the editors stated that it
aimed at helping the journal to reach out to the broader
medical community and to reconcile “the journal’s iden-
tity with its 21st century content.” [22]. However, the
new subtitle hasn’t led to a measurable increase in the
journal’s impact factor over the subsequent years. The
editors continued that “Some day in the not-too-distant
future, this journal may no longer be called Psycho-
somatic Medicine. It may eventually become Biobehav-
ioral Medicine, or perhaps The Journal of Biobehavioral
Medicine” [22].
This occurred during a phase of discussions within
the membership of APS whether it should not better
change its name in total. Several members had sev-
eral reasons for considering a name change. Its partly
negative connotation among somatic clinicians and
the lay public, who often use it in a stigmatizing
way, was one key argument. Unlike other countries
such as Germany or Japan, the term “psychosomatic”
has negative connotations among the lay public and
many health practitioners in the United States, where
it is often equated with imaginary symptoms rather
than (measurable) mind-body interactions. In
addition, the term was thought to perpetuate the
mind-body dualism it originally intended to over-
come by, eg, ignoring the social dimension. Finally,
many behaviorally or biologically oriented researchers
perceived “psychosomatic” as too closely linked to
“psychoanalytic”. In fact, psychoanalytic psychiatry
while having been at the heart of APS in its early
years has been the theoretical and clinical back-
ground of only a small minority of members in re-
cent years. A majority of members now understand
themselves as behavioral, biological or “biobehavioral”
researchers, as epidemiologists, neuroscientists or
physician scientists. The name change discussions
started in the late 1990s and several alternative
names were brought up during the process. However,
none of the alternative names developed sufficient
traction to justify the abandonment of history and
the costs associated with rebranding.
The discussion only came to an end after a mem-
bership vote in 2013, where members were finally in-
vited to decide whether they wanted to keep the
historical name or rename the society to “Association
for Biopsychosocial Medicine”. Although “biopsycho-
social” was widely acknowledged to cover the inter-
personal and social aspects of psychosomatic
medicine better than the original term, a majority fi-
nally voted in favor of keeping the original name [23].
This does not necessarily indicate broad support for
the term “psychosomatic”. However, the predominat-
ing opinion appeared to be that it might be more fa-
vorable to educate the public about the real focus of
the field and the research APS members are conduct-
ing, so that the term “psychosomatic” might regain
the positive holistic implication it originally had, ra-
ther than adopting one of the alternative proposals
which also all appeared suboptimal to many members
and might have raised new problems.
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APS’ current mission, goals and strategies
So APS is still the American Psychosomatic Society
when it comes to celebrating its 75th anniversary in
2017/18. However, APS has, in early 2016, refined its
goals, adapted a new mission and strategic goals and
launched a number of activities to achieve those goals
[24, 25].
The mission statement as published on the APS web-
site (www.psychosomatic.org) now reads: “To advance
and integrate the scientific study of biological, psycho-
logical, behavioral and social factors in health and
disease.”
Based on the mission and APS’ core values, three stra-
tegic goals were prioritized:
 Scientific excellence: Advance scientific excellence
in psychosomatic medicine
 Clinical relevance: Increase clinical and public
health relevance of biopsychosocial research
 Vibrant and diverse membership: Ensure an
engaged membership balanced by disciplines, career
stages, national/ethnic backgrounds, clinical vs. basic
researchers.
Several ongoing and newly adopted strategies are un-
derway to reach these goals and each of the strategies is
supported by one or more specific tactics.
Strategies related to the goal of scientific excellence
include:
 Publish papers in Psychosomatic Medicine that
would be routinely cited in Introduction and
Methods sections of papers
 Provide training to students and fellows on how to
review for the journal
 Integrate affect science and psychobiology to
advance scientific rigor and clinical relevance
in psychosomatic medicine. This strategy is
expected to build on the initial intention of
the society to study associations between
“Emotions and Bodily Changes” [1] and redefine
it for the 21st century. It is also intended to
increase clinical relevance of research. Tactics
include, among others
– A special topic meeting in the fall of 2017,
focusing on “Emotions in Social Relationships –
Implications for Health and Disease”, together
with a special issue in Psychosomatic Medicine
and an Anniversary Award related to the topic
of the meeting
– Invited Symposia and Speakers at Annual
Meetings
– Experienced Investigator Colloquium at Annual
Meeting
 Setup infrastructure for collaborative research: APS
will join and support an initiative for creating a
Behavioral Medicine Research Council (BMRC),
aiming at integrating efforts across organizations
to clarify major biobehavioral research questions
and guiding scientific directions to advance
and coordinate clinically relevant science in
biobehavioral medicine.
 Collaborate with the Consortium of Social Science
Associations (COSSA [26]), providing a united
voice for social and behavioral science in US
political affairs.
The following strategies are related to the goal of clin-
ical relevance:
 Education: APS is working with authors of
educational videos and other materials for the
APS website to translate research findings into
clinical application. APS members are also working
on a comprehensive educational textbook on
psychosomatic medicine and on educational
programming during Annuals Meetings
 APS is liaising with the Integrated Primary Care
Alliance(IPCA) to improve biopsychosocial
understanding and practice in primary care settings
 A dedicated Clinical Series is being prepared for
Psychosomatic Medicine
 APS started cross-advertizing for events with the
Academy of Psychosomatic Medicine as a mainly
clinically-oriented partner society.
As related to the goal of fostering a vibrant and diverse
membership the following initiatives are underway:
 Several ongoing scholar and travel awards mainly
targeting trainees and junior scientists from the US
and worldwide
 A new international lab-to-lab exchange program
[27] for which APS is collaborating with the
International Society for Behavioral Medicine
(ISBM) and the Society for Health Psychology
 The anniversary awards mentioned above, which
offer an opportunity for senior and mid-career
researcher to get their outstanding work
recognized beyond the existing APS awards such as
the Herbert Weiner Early Career Award, the MacLean
Award for outstanding neuroscience research in
Psychosomatic Medicine, the Patricia A. Barchas
Award for Sociophysiology, the Distinguished
Scientist Award and the Donald Oken Fellowship
honoring a distinguished consultation-liaison
psychiatrist or internist who hasn’t previously
attended an APS meeting.
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Conclusion
This year, APS is celebrating its 75th anniversary [28],
starting with the 2017 Annual Meeting which was held
in Sevilla, Spain on March 15–18, 2017, following a trad-
ition adopted in 2002 to hold an Annual Meeting out-
side North America every 5 years to facilitate interaction
with international researchers and clinicians in the field.,
Anniversary celebrations are continuing through the
special topic meeting on “Emotions in Social Relation-
ships – Implications for Health and Disease”, which will
take place in Berkeley, California, on October 20-21st,
2017 and culminate in a series of events during the 2018
Annual Meeting, which will take place in Louisville,
Kentucky on March 7–10, 2018. For the anniversary cel-
ebrations, APS is currently conducting some research
into its history, taking advantage of a rich pool of ar-
chived materials ranging back to the very beginnings of
the society, collecting historical memories by interviews
with senior members and addressing historical aspects
during the jubilee meetings. Readers are cordially invited
to submit historical materials to the APS national office
at info@psychosomatic.org and to join us in celebrating
the 75th anniversary and developing American and inter-
national psychosomatic medicine into the future.
Acknowledgement
Special thanks goes to Doug Drossman for critically commenting on an
earlier draft of this paper and to Richard Lane for helpful comments during
the review process. Some of the materials cited in this article are courtesy
of the Oskar Diethelm Library, DeWitt Wallace Institute for the History of
Psychiatry, Weill Cornell Medical College, keeping APS’ historical archives.
Funding
This article was prepared with basic institutional funding only and with no
external funding.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or
analyzed during the current study
Author’s contribution
CHL gathered and reviewed the literature and the unpublished documents.
He also wrote the manuscript.
Competing interests
At the time of manuscript preparation, the author was the President of the
American Psychosomatic Society, which may be perceived as a non-financial
competing interest. He declares that he has no competing financial interests
related to the content of this manuscript.
Consent for publication
Not applicable
Ethics approval and consent to participate
Not applicable
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 3 February 2017 Accepted: 3 April 2017
References
1. Dunbar HF. Emotions and bodily changes, a survey of literature on
psychosomatic interrelationships 1910–1933. New York: Columbia University
Press; 1935.
2. Levenson D. Mind, body, and medicine – a history of the American
Psychosomatic Society. Baltimore: Williams & Wilkins; 1994.
3. Psychosomatic Medicine Editors. Introductory statement. Psychosom Med.
1939;1:3–5.
4. Psychosomatic Medicine Editors. Inauguration of the American society for
research in psychosomatic problems. Psychosom Med. 1943;5:97.
5. Zilboorg G. Clinical transformations in psychiatry and psychoanalysis. J Am
Med Assoc. 1959;171:648–51.
6. American Psychosomatic Society: About APS. http://www.psychosomatic.
org/about/index.cfm (2017). Accessed 30 Jan 2017.
7. Margolin SG. Proposed constitutional amendments. Psychosom Med. 1948;
10:52–3.
8. Margolin SG. Statement on society policy. Psychosom Med. 1948;10:52.
9. Psychosomatic Medicine Editors. American psychosomatic society.
Psychosom Med. 1951;13:322.
10. Wittkower ED. News of the Society -Twenty Years of North American
Psychosomatic Medicine. Psychosom Med. 1960;22:308–16.
11. Binger C. Editorial Notes. Psychosom Med. 1960;22:249–50.
12. Mason JW. Strategy in psychosomatic research. Psychosom Med. 1970;32:
427–39.
13. Singer MT. Presidential address. Engagement-involvement: a central
phenomenon in psychophysiological research. Psychosom Med. 1974;
36:1–17.
14. Stunkard AJ. Presidential address-1974 from explanation to action in
psychosomatic medicine: the case of obesity. Psychosom Med. 1975;37:
195–236.
15. Shapiro AP. Presidential address–1975: before the colors fade. Psychosom
Med. 1975;37:292–305.
16. Ader R. Presidential address–1980. Psychosomatic and psychoimmunologic
research. Psychosom Med. 1980;42:307–21.
17. Graham DT. Presidential address–1979. What place in medicine for
psychosomatic medicine? Psychosom Med. 1979;41:357–67.
18. Engel GL. The need for a new medical model: a challenge for biomedicine.
Science. 1977;196:129–36.
19. Jenkins CD. New horizons for psychosomatic medicine. Psychosom Med.
1985;47:3–25.
20. Drossman D, Weiss T, Rahe RH, Mitchell CM. Who are we? the American
psychosomatic society membership survey. PsychosomMed. 1989;51:648–51.
21. Lane RD, Lovallo WR. How the Paul D. MacLean Award for Outstanding
Neuroscience Research in Psychosomatic Medicine Came to Be.
http://www.psychosomatic.org/NewsWinter2014/MacLeanHistory.cfm
(2014). Accessed 25 Mar 2017.
22. Freedland KE, de Geus EJ, Golden RN, Kop WJ, Miller GE, Vaccarino V,
Brumback B, Llabre MM, White VJ, Sheps DS. What’s in a name?
Psychosomatic medicine and biobehavioral medicine. Psychosom Med.
2009;71(1):1–4.
23. Lutgendorf S. President’s Message. http://www.psychosomatic.org/
NewsWinter2014/Winter2014NL.cfm (2014). Accessed 30 Jan 2017.
24. Al’Absi M. President’s Message. http://www.psychosomatic.org/
NewsWinter2016/Winter2016NL.cfm (2016). Accessed 30 Jan 2017.
25. Herrmann-Lingen C. President’s Message. http://www.psychosomatic.org/
NewsSpring2016/Spring2016NL.cfm (2016). Accessed January 30, 2017.
26. Consortium of Social Science Associations: About COSSA. http://www.cossa.
org/about/ (2017). Accessed 30 Jan 2017.
27. American Psychosomatic Society: Health and Behavior International
Collaborative Award. http://www.psychosomatic.org/awards/PDF/
HealthandBehaviorInternationalCollaborativeAwardApplication9-2-16.pdf
(2016). Accessed 30 Jan 2017.
28. Reed RG. The American Psychosomatic Society’s 75th Anniversary
Celebration http://www.psychosomatic.org/NewsWinter2017/Anniversary.
cfm (2017). Accessed 1 Feb 2017.
Herrmann-Lingen BioPsychoSocial Medicine  (2017) 11:11 Page 7 of 7
